1-[6-(3,10-diphenylanthracen-9-yl)-2-pyridinyl]-2-ethylbenzimidazole;2-ethyl-1-[6-(10-naphthalen-1-yl-3-phenylanthracen-9-yl)-3-pyridinyl]benzimidazole;2-ethyl-1-[6-(10-naphthalen-2-yl-3-phenylanthracen-9-yl)-2-pyridinyl]benzimidazole;2-ethyl-1-[6-[3-phenyl-10-(4-phenylphenyl)anthracen-9-yl]-2-pyridinyl]benzimidazole

C174H124N12 — CID 167571587

IUPAC1-[6-(3,10-diphenylanthracen-9-yl)-2-pyridinyl]-2-ethylbenzimidazole;2-ethyl-1-[6-(10-naphthalen-1-yl-3-phenylanthracen-9-yl)-3-pyridinyl]benzimidazole;2-ethyl-1-[6-(10-naphthalen-2-yl-3-phenylanthracen-9-yl)-2-pyridinyl]benzimidazole;2-ethyl-1-[6-[3-phenyl-10-(4-phenylphenyl)anthracen-9-yl]-2-pyridinyl]benzimidazole
SMILESCCc1nc2ccccc2n1-c1ccc(-c2c3ccccc3c(-c3cccc4ccccc34)c3cc(-c4ccccc4)ccc23)nc1.CCc1nc2ccccc2n1-c1cccc(-c2c3ccccc3c(-c3ccc(-c4ccccc4)cc3)c3cc(-c4ccccc4)ccc23)n1.CCc1nc2ccccc2n1-c1cccc(-c2c3ccccc3c(-c3ccc4ccccc4c3)c3cc(-c4ccccc4)ccc23)n1.CCc1nc2ccccc2n1-c1cccc(-c2c3ccccc3c(-c3ccccc3)c3cc(-c4ccccc4)ccc23)n1
InChIInChI=1S/C46H33N3.2C44H31N3.C40H29N3/c1-2-43-47-40-20-11-12-22-42(40)49(43)44-23-13-21-41(48-44)46-37-19-10-9-18-36(37)45(34-26-24-33(25-27-34)31-14-5-3-6-15-31)39-30-35(28-29-38(39)46)32-16-7-4-8-17-32;1-2-42-46-39-21-10-11-22-41(39)47(42)32-24-26-40(45-28-32)44-36-19-9-8-18-35(36)43(34-20-12-16-30-15-6-7-17-33(30)34)38-27-31(23-25-37(38)44)29-13-4-3-5-14-29;1-2-41-45-38-19-10-11-21-40(38)47(41)42-22-12-20-39(46-42)44-35-18-9-8-17-34(35)43(33-24-23-30-15-6-7-16-31(30)27-33)37-28-32(25-26-36(37)44)29-13-4-3-5-14-29;1-2-37-41-34-20-11-12-22-36(34)43(37)38-23-13-21-35(42-38)40-31-19-10-9-18-30(31)39(28-16-7-4-8-17-28)33-26-29(24-25-32(33)40)27-14-5-3-6-15-27/h3-30H,2H2,1H3;2*3-28H,2H2,1H3;3-26H,2H2,1H3
InChIKeyFZAXDGWIXLDLHA-UHFFFAOYSA-N
MW2382.99 g/mol
LogP45.13
Rot. Bonds21

About 1-[6-(3,10-diphenylanthracen-9-yl)-2-pyridinyl]-2-ethylbenzimidazole;2-ethyl-1-[6-(10-naphthalen-1-yl-3-phenylanthracen-9-yl)-3-pyridinyl]benzimidazole;2-ethyl-1-[6-(10-naphthalen-2-yl-3-phenylanthracen-9-yl)-2-pyridinyl]benzimidazole;2-ethyl-1-[6-[3-phenyl-10-(4-phenylphenyl)anthracen-9-yl]-2-pyridinyl]benzimidazole

1-[6-(3,10-diphenylanthracen-9-yl)-2-pyridinyl]-2-ethylbenzimidazole;2-ethyl-1-[6-(10-naphthalen-1-yl-3-phenylanthracen-9-yl)-3-pyridinyl]benzimidazole;2-ethyl-1-[6-(10-naphthalen-2-yl-3-phenylanthracen-9-yl)-2-pyridinyl]benzimidazole;2-ethyl-1-[6-[3-phenyl-10-(4-phenylphenyl)anthracen-9-yl]-2-pyridinyl]benzimidazole (PubChem CID 167571587) has the molecular formula C174H124N12 and a molecular weight of 2382.99 g/mol. Its IUPAC name is 1-[6-(3,10-diphenylanthracen-9-yl)-2-pyridinyl]-2-ethylbenzimidazole;2-ethyl-1-[6-(10-naphthalen-1-yl-3-phenylanthracen-9-yl)-3-pyridinyl]benzimidazole;2-ethyl-1-[6-(10-naphthalen-2-yl-3-phenylanthracen-9-yl)-2-pyridinyl]benzimidazole;2-ethyl-1-[6-[3-phenyl-10-(4-phenylphenyl)anthracen-9-yl]-2-pyridinyl]benzimidazole.

Molecular Properties

Compound Name1-[6-(3,10-diphenylanthracen-9-yl)-2-pyridinyl]-2-ethylbenzimidazole;2-ethyl-1-[6-(10-naphthalen-1-yl-3-phenylanthracen-9-yl)-3-pyridinyl]benzimidazole;2-ethyl-1-[6-(10-naphthalen-2-yl-3-phenylanthracen-9-yl)-2-pyridinyl]benzimidazole;2-ethyl-1-[6-[3-phenyl-10-(4-phenylphenyl)anthracen-9-yl]-2-pyridinyl]benzimidazole
PubChem CID167571587
Molecular FormulaC174H124N12
Molecular Weight2382.99 g/mol
Exact Mass2381.01
IUPAC Name1-[6-(3,10-diphenylanthracen-9-yl)-2-pyridinyl]-2-ethylbenzimidazole;2-ethyl-1-[6-(10-naphthalen-1-yl-3-phenylanthracen-9-yl)-3-pyridinyl]benzimidazole;2-ethyl-1-[6-(10-naphthalen-2-yl-3-phenylanthracen-9-yl)-2-pyridinyl]benzimidazole;2-ethyl-1-[6-[3-phenyl-10-(4-phenylphenyl)anthracen-9-yl]-2-pyridinyl]benzimidazole
SMILESCCc1nc2ccccc2n1-c1ccc(-c2c3ccccc3c(-c3cccc4ccccc34)c3cc(-c4ccccc4)ccc23)nc1.CCc1nc2ccccc2n1-c1cccc(-c2c3ccccc3c(-c3ccc(-c4ccccc4)cc3)c3cc(-c4ccccc4)ccc23)n1.CCc1nc2ccccc2n1-c1cccc(-c2c3ccccc3c(-c3ccc4ccccc4c3)c3cc(-c4ccccc4)ccc23)n1.CCc1nc2ccccc2n1-c1cccc(-c2c3ccccc3c(-c3ccccc3)c3cc(-c4ccccc4)ccc23)n1
InChIInChI=1S/C46H33N3.2C44H31N3.C40H29N3/c1-2-43-47-40-20-11-12-22-42(40)49(43)44-23-13-21-41(48-44)46-37-19-10-9-18-36(37)45(34-26-24-33(25-27-34)31-14-5-3-6-15-31)39-30-35(28-29-38(39)46)32-16-7-4-8-17-32;1-2-42-46-39-21-10-11-22-41(39)47(42)32-24-26-40(45-28-32)44-36-19-9-8-18-35(36)43(34-20-12-16-30-15-6-7-17-33(30)34)38-27-31(23-25-37(38)44)29-13-4-3-5-14-29;1-2-41-45-38-19-10-11-21-40(38)47(41)42-22-12-20-39(46-42)44-35-18-9-8-17-34(35)43(33-24-23-30-15-6-7-16-31(30)27-33)37-28-32(25-26-36(37)44)29-13-4-3-5-14-29;1-2-37-41-34-20-11-12-22-36(34)43(37)38-23-13-21-35(42-38)40-31-19-10-9-18-30(31)39(28-16-7-4-8-17-28)33-26-29(24-25-32(33)40)27-14-5-3-6-15-27/h3-30H,2H2,1H3;2*3-28H,2H2,1H3;3-26H,2H2,1H3
InChIKeyFZAXDGWIXLDLHA-UHFFFAOYSA-N
XLogP45.13
TPSA122.84 Ų
H-Bond Donors
H-Bond Acceptors12
Rotatable Bonds21
Heavy Atoms186
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002382.99
LogP ≤ 545.13
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_2', 'substructure': 'N/A'}

Analyze 1-[6-(3,10-diphenylanthracen-9-yl)-2-pyridinyl]-2-ethylbenzimidazole;2-ethyl-1-[6-(10-naphthalen-1-yl-3-phenylanthracen-9-yl)-3-pyridinyl]benzimidazole;2-ethyl-1-[6-(10-naphthalen-2-yl-3-phenylanthracen-9-yl)-2-pyridinyl]benzimidazole;2-ethyl-1-[6-[3-phenyl-10-(4-phenylphenyl)anthracen-9-yl]-2-pyridinyl]benzimidazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[6-(3,10-diphenylanthracen-9-yl)-2-pyridinyl]-2-ethylbenzimidazole;2-ethyl-1-[6-(10-naphthalen-1-yl-3-phenylanthracen-9-yl)-3-pyridinyl]benzimidazole;2-ethyl-1-[6-(10-naphthalen-2-yl-3-phenylanthracen-9-yl)-2-pyridinyl]benzimidazole;2-ethyl-1-[6-[3-phenyl-10-(4-phenylphenyl)anthracen-9-yl]-2-pyridinyl]benzimidazole?
The IUPAC name of 1-[6-(3,10-diphenylanthracen-9-yl)-2-pyridinyl]-2-ethylbenzimidazole;2-ethyl-1-[6-(10-naphthalen-1-yl-3-phenylanthracen-9-yl)-3-pyridinyl]benzimidazole;2-ethyl-1-[6-(10-naphthalen-2-yl-3-phenylanthracen-9-yl)-2-pyridinyl]benzimidazole;2-ethyl-1-[6-[3-phenyl-10-(4-phenylphenyl)anthracen-9-yl]-2-pyridinyl]benzimidazole (CID 167571587) is 1-[6-(3,10-diphenylanthracen-9-yl)-2-pyridinyl]-2-ethylbenzimidazole;2-ethyl-1-[6-(10-naphthalen-1-yl-3-phenylanthracen-9-yl)-3-pyridinyl]benzimidazole;2-ethyl-1-[6-(10-naphthalen-2-yl-3-phenylanthracen-9-yl)-2-pyridinyl]benzimidazole;2-ethyl-1-[6-[3-phenyl-10-(4-phenylphenyl)anthracen-9-yl]-2-pyridinyl]benzimidazole.
What is the SMILES notation for 1-[6-(3,10-diphenylanthracen-9-yl)-2-pyridinyl]-2-ethylbenzimidazole;2-ethyl-1-[6-(10-naphthalen-1-yl-3-phenylanthracen-9-yl)-3-pyridinyl]benzimidazole;2-ethyl-1-[6-(10-naphthalen-2-yl-3-phenylanthracen-9-yl)-2-pyridinyl]benzimidazole;2-ethyl-1-[6-[3-phenyl-10-(4-phenylphenyl)anthracen-9-yl]-2-pyridinyl]benzimidazole?
The canonical SMILES for 1-[6-(3,10-diphenylanthracen-9-yl)-2-pyridinyl]-2-ethylbenzimidazole;2-ethyl-1-[6-(10-naphthalen-1-yl-3-phenylanthracen-9-yl)-3-pyridinyl]benzimidazole;2-ethyl-1-[6-(10-naphthalen-2-yl-3-phenylanthracen-9-yl)-2-pyridinyl]benzimidazole;2-ethyl-1-[6-[3-phenyl-10-(4-phenylphenyl)anthracen-9-yl]-2-pyridinyl]benzimidazole is CCc1nc2ccccc2n1-c1ccc(-c2c3ccccc3c(-c3cccc4ccccc34)c3cc(-c4ccccc4)ccc23)nc1.CCc1nc2ccccc2n1-c1cccc(-c2c3ccccc3c(-c3ccc(-c4ccccc4)cc3)c3cc(-c4ccccc4)ccc23)n1.CCc1nc2ccccc2n1-c1cccc(-c2c3ccccc3c(-c3ccc4ccccc4c3)c3cc(-c4ccccc4)ccc23)n1.CCc1nc2ccccc2n1-c1cccc(-c2c3ccccc3c(-c3ccccc3)c3cc(-c4ccccc4)ccc23)n1.
What is the InChIKey of 1-[6-(3,10-diphenylanthracen-9-yl)-2-pyridinyl]-2-ethylbenzimidazole;2-ethyl-1-[6-(10-naphthalen-1-yl-3-phenylanthracen-9-yl)-3-pyridinyl]benzimidazole;2-ethyl-1-[6-(10-naphthalen-2-yl-3-phenylanthracen-9-yl)-2-pyridinyl]benzimidazole;2-ethyl-1-[6-[3-phenyl-10-(4-phenylphenyl)anthracen-9-yl]-2-pyridinyl]benzimidazole?
The InChIKey is FZAXDGWIXLDLHA-UHFFFAOYSA-N. The full InChI is InChI=1S/C46H33N3.2C44H31N3.C40H29N3/c1-2-43-47-40-20-11-12-22-42(40)49(43)44-23-13-21-41(48-44)46-37-19-10-9-18-36(37)45(34-26-24-33(25-27-34)31-14-5-3-6-15-31)39-30-35(28-29-38(39)46)32-16-7-4-8-17-32;1-2-42-46-39-21-10-11-22-41(39)47(42)32-24-26-40(45-28-32)44-36-19-9-8-18-35(36)43(34-20-12-16-30-15-6-7-17-33(30)34)38-27-31(23-25-37(38)44)29-13-4-3-5-14-29;1-2-41-45-38-19-10-11-21-40(38)47(41)42-22-12-20-39(46-42)44-35-18-9-8-17-34(35)43(33-24-23-30-15-6-7-16-31(30)27-33)37-28-32(25-26-36(37)44)29-13-4-3-5-14-29;1-2-37-41-34-20-11-12-22-36(34)43(37)38-23-13-21-35(42-38)40-31-19-10-9-18-30(31)39(28-16-7-4-8-17-28)33-26-29(24-25-32(33)40)27-14-5-3-6-15-27/h3-30H,2H2,1H3;2*3-28H,2H2,1H3;3-26H,2H2,1H3.
What are the key properties of 1-[6-(3,10-diphenylanthracen-9-yl)-2-pyridinyl]-2-ethylbenzimidazole;2-ethyl-1-[6-(10-naphthalen-1-yl-3-phenylanthracen-9-yl)-3-pyridinyl]benzimidazole;2-ethyl-1-[6-(10-naphthalen-2-yl-3-phenylanthracen-9-yl)-2-pyridinyl]benzimidazole;2-ethyl-1-[6-[3-phenyl-10-(4-phenylphenyl)anthracen-9-yl]-2-pyridinyl]benzimidazole?
1-[6-(3,10-diphenylanthracen-9-yl)-2-pyridinyl]-2-ethylbenzimidazole;2-ethyl-1-[6-(10-naphthalen-1-yl-3-phenylanthracen-9-yl)-3-pyridinyl]benzimidazole;2-ethyl-1-[6-(10-naphthalen-2-yl-3-phenylanthracen-9-yl)-2-pyridinyl]benzimidazole;2-ethyl-1-[6-[3-phenyl-10-(4-phenylphenyl)anthracen-9-yl]-2-pyridinyl]benzimidazole has a molecular weight of 2382.99 g/mol, XLogP of 45.13, 21 rotatable bonds, 0 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[6-(3,10-diphenylanthracen-9-yl)-2-pyridinyl]-2-ethylbenzimidazole;2-ethyl-1-[6-(10-naphthalen-1-yl-3-phenylanthracen-9-yl)-3-pyridinyl]benzimidazole;2-ethyl-1-[6-(10-naphthalen-2-yl-3-phenylanthracen-9-yl)-2-pyridinyl]benzimidazole;2-ethyl-1-[6-[3-phenyl-10-(4-phenylphenyl)anthracen-9-yl]-2-pyridinyl]benzimidazole is sourced from PubChem (CID 167571587), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).